An integrated analysis for long noncoding RNAs and microRNAs with the mediated competing endogenous RNA network in

Chuiguo Huang1, Naijun Yuan2, Liying Wu3

  • 1Department of Urology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou.

Oncotargets and Therapy
|September 2, 2017
PubMed

Insights

This study reveals a crucial competing endogenous RNA (ceRNA) network involving long noncoding RNAs (lncRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) in papillary renal cell carcinoma (PRCC) progression. The findings offer potential molecular biomarkers for PRCC diagnosis and treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Papillary renal cell carcinoma (PRCC) lacks effective therapeutic targets and prognostic biomarkers.
  • Long noncoding RNAs (lncRNAs) are implicated in tumorigenesis via competing endogenous RNA (ceRNA) networks.
  • Understanding the lncRNA-mediated ceRNA network in PRCC is critical for identifying novel therapeutic strategies.

Purpose of the Study:

  • To elucidate the functional roles of lncRNAs in the ceRNA network within PRCC.
  • To identify key differentially expressed molecules (mRNAs, lncRNAs, miRNAs) involved in PRCC pathogenesis.
  • To construct and visualize the PRCC-specific ceRNA network.

Main Methods:

  • Utilized The Cancer Genome Atlas (TCGA) data for 289 PRCC and 32 normal tissues.
  • Performed differential expression analysis for mRNAs, lncRNAs, and miRNAs.
  • Employed weighted gene co-expression network analysis (WGCNA) to identify hub genes.
  • Constructed the ceRNA network using Cytoscape software.

Main Results:

  • Identified 2,197 differentially expressed mRNAs (DEmRNAs) and 84 differentially expressed miRNAs (DEmiRNAs).
  • Discovered 28 hub DEmRNAs as potential key target genes.
  • Found 7 dysregulated DEmiRNAs significantly associated with hub DEmRNAs.
  • Identified 16 differentially expressed lncRNAs interacting with DEmiRNAs, forming a PRCC ceRNA network.

Conclusions:

  • The constructed ceRNA network plays a significant role in PRCC progression.
  • Specific genes within this network show strong correlations with clinical prognosis.
  • These findings provide potential molecular biomarkers for PRCC diagnosis and targeted therapy.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K